Posted in Physician Payment Sunshine Act on February 20, 2013
For years, the pharmaceutical industry has targeted physicians and teaching hospitals to help them market their products. Drug companies provide free samples of their product for physician’s to use and offer lucrative opportunities for those who promote their drug, including gifts, dining and entertainment, lecturing opportunities in resort destinations and other forms of payment. This…
read more
Posted in Fosamax® on February 7, 2013
Over 4,000 lawsuits involving Fosamax®, an osteoporosis drug manufactured by Merck & Co., Inc., are pending in federal and state courts. On February 5, 2013, in Scheinberg v. Merck & Co, Inc., Merck encountered its second loss out of seven cases in which the company will pay $285,000 to the plaintiff, Rhoda Scheinberg. The 69-year-old…
read more
Posted in Defective Medical Devices,FDA Regulations on January 21, 2013
Undergoing hip replacement surgery is demanding of the body and requires weeks, months, or up to years, of recovery and rehabilitation, but the final result of improved mobility and well-being usually makes the process worth it. Unfortunately, according to The New York Times, about 500,000 patients who received metal-on-metal hip replacements have reported hip implant…
read more
Posted in Unfair Business Practices on April 16, 2010
“The 4-3 holding breathed new life into Unfair Competition Law class actions in which consumers allege they relied on misleading statements and advertising”
Posted in Employment Law,Products Liability,Toxic Substances on December 8, 2009
“Imposing a duty toward nonemployee persons saddles the defendant employer with a burden of uncertain but potentially very large scope.”
Posted in Pharmaceutical Injuries on June 16, 2009
In a conference call with a group of reporters this morning the FDA announced it is warning users of Zicam, a popular cold-relief nasal spray, to stop using the product because it has been associated with approximately 130 reported cases of people losing their sense of smell. The FDA stated that it had sent Matrixx…
read more
Posted in Products Liability on November 19, 2008
This week top executives of the ‘Big Three’ automakers are on Capitol Hill asking Congress for $25 billion in government bailout money. Even before the recent economic crisis things were not going well for American automotive giants. Sales had been sliding along with their market share, and the downturn of the last few months has…
read more
Posted in Products Liability on March 1, 2008
Products Liability & Injury Lawyer Law Blog Welcome to the Products Liability and Injury Lawyer Blog. This site is intended to be a source of information for the legal profession as well as the general public, on recent appellate court decisions and news items, and changes and developments in the law, relating to personal injury…
read more
